Results 201 to 210 of about 100,543 (354)

Lewis G. Brown, Part 3

open access: yes, 2008
Location: MontserradoRuntime: 4:46:36Hearing Type: Institutional and ThematicCategorized as pertaining to Diaspora, Hearings.The Truth and Reconciliation Commission of ...
Lewis G. Brown
core  

Dose‐dependent hepatotoxicity of hydrogen peroxide in HepG2 cells and its modulation by CYP450 induction

open access: yesFEBS Open Bio, EarlyView.
NMR metabolomics revealed concentration‐dependent metabolic perturbations in HepG2 cells exposed to H2O2. Rifampicin pretreatment enhanced metabolic competence, attenuated toxin‐induced alterations and produced metabolite profiles more consistent with human liver physiology, supporting the use of CYP450‐induced HepG2 models for improved in vitro ...
Maren Jinks   +4 more
wiley   +1 more source

Modern Perspectives on 30-Day Hospital Readmission Reviews. [PDF]

open access: yesCureus
Kurapati R   +6 more
europepmc   +1 more source

Women's Panel: Liberian Women's Initiative -- Minnesota: Tetee Cole

open access: yes, 2008
Categorized as pertaining to Diaspora, Hearings.Location: Hamline University; St.
Cole, Tetee
core  

Aging Is a Key Driver for Adult Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley   +1 more source

Edward Slangar, Part 17

open access: yes, 2008
Location: MontserradoRuntime: 0:34:47Hearing Type: Institutional and ThematicCategorized as pertaining to Diaspora, Hearings.The Truth and Reconciliation Commission of ...
Edward Slangar
core  

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

open access: yesAging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy